An inhaled nitric oxide dose of 20 ppm produces a faster response than 5 ppm in adult respiratory distress syndrome;La administracion de 20 ppm de oxido nitrico inhalado produce una respuesta mas rapida que la inhalacion de 5 ppm en el sindrome de distres respiratorio del adulto

Revista Espanola de Anestesiologia y Reanimacion

Volumn 47, Issue 2, 2000, Pages 57-62

  Diaz Reganon Valverde, G ^a   Fernandez Rico R ^a   Iribarren Sarrias J L ^a   Lopez Sanchez M ^a   Iglesias Fraile, L ^a   Ibanez Elejalde E ^a   Rodriguez Borregan J C ^a   Gonzalez Herrera S ^a   Garrido Diaz C ^a   Lopez Espadas F ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Acute pulmonary lesion; Acute respiratory failure; Adult respiratory distress syndrome; Nitric oxide

Indexed keywords

NITRIC OXIDE; UNCLASSIFIED DRUG; VANIDAL A; BRONCHODILATING AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTERIAL OXYGEN SATURATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; FEMALE; HEART INDEX; HUMAN; LUNG VASCULAR RESISTANCE; MALE; OXYGEN TRANSPORT; OXYGENATION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE; TREATMENT OUTCOME; COMPARATIVE STUDY; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

ADMINISTRATION, INHALATION; BRONCHODILATOR AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0343416145     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2: 319-323.
2. a ed). Edimburgo: Churchill Livingstone, 1995; 509-525.
3. Suchyta MR, Clemmer TP, Elliot CG, Orme JF, Weaver LK. The ARDS: a report of survival and modifying factors. Chest 1992; 101: 1.074-1.079.
4. Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 1995; 273: 306-309.
5. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138: 720-723.
6. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L et al. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Int Care Med 1994; 20: 225-232.
7. Bigatello LM, Hurford WE, Kacmarek RM, Roberts JD, Zapol WM. Prolonged inhalation of low concentration of nitric oxide in patients with severe adult distress syndrome. Effects on pulmonary hemodynamics and oxygenation. Anesthesiology 1994; 80: 761-770.
8. Lewan Meddonski K, Rossaint R, Pappert D, Gerlach H, Slama K-J, Weideman H et al. High survival rate in 122 ARDS patients managed according to a clinical algorihm including extracorporeal membrane oxigenation. Int Care Med 1997; 23: 819-835.
9. Gillbe CE, Salt JC, Branthwaite MA. Pulmonary function after prolonged mechanical ventilation with high concentrations of oxygen. Thorax 1980; 35: 907-913.
10. Risberg B, Smith L, Ortenwall P. Oxygen radicals and lung injury. Acta Anaesthesiol Scand 1991; 35 (Supl 95): 106-118.
11. Rademacher P, Bantak B, Becker H, Falke K. Protaglandin E1 and nytroglicerin reduce pulmonary capillary pressure but worsen ventilation-perfussion distribution in patiens with adult respiratory distress syndrome. Anesthesiology 1987; 70: 601-606.
12. Furchgott RF, Zawadski JV. The obligatory role of endothelium in the relaxation of arterial smooth muscle by acetylcoline. Nature 1980; 288: 373-376.
13. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526
14. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9.265-9.269
15. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666.
16. Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz MI, Pitt B. Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 1989; 79: 287-291.
17. Creager MA, Cooke JP, Mendelsohn ME, Gallager SJ, Coleman SM. Loscalzo J et al. Impaired vasodilation of forearms resistance vessels in hypercolesterolemic humans. J Clin Invest 1990; 86: 228-234.
18. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27.
19. Halkin A, Benjamin N, Doktor HS, Todd SD, Viberti GC, Ritter JM. Vascular responsiveness and cation exchange in insulin dependent diabetes. Clin Sci 1991; 81: 223-232.
20. Giacoia GP. Nitric oxide: a selective pulmonary vasodilatador. South Med J 1995; 88: 33-41.
21. Abman SH, Griebel JL, Parker DK, Schmidt JM, Swanton D, Kinsella JP. Acute effects of inhaled nitric oxide in children with sevre hypoxemic respiratory failure. J Pediatr 1994; 124: 881-889.
22. Rossaint R, Falke KJ, López F, Slama K, Pison U, Zappol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328: 399-405.
23. Gerlach H, Pappert D, Lewadowski K, Rossaint R, Falke KJ. Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxigenation in patients with adult respiratory distress syndrome. Int Care Med 1993; 19: 443-449.
24. Puybasset L, Rouby JJ, Mourgeon EW, Stewart TE, Cluzel P. Inhaled nitric oxide in acute respiratory failure: dose-response curves. Int Care Med 1994; 20: 319-327.
25. Betsebé AJ, Pérez M, Bak E, Ballús A, Net A, Mancebo J. Efectos gasométricos y hemodinámicos de la inhalación de óxido nítrico en pacientes con síndrome de distrés respiratorio agudo. Med Clin (Barc) 1996; 107: 201-206.
26. Ichinose F, Hurford WE, Zappol WM. Evaluation of inhaled nitric oxide in experimental models of lung injury. En: Zappol WM, Kenneth DB. editores. Nitric oxide and the lung. Nueva York: Marcel Dekker, 1997; 251-270.
27. Dellinger LP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ et al, and the Inhaled Nitric Oxide in ARDS Study Group. Effects of inhaled nitric oxide in patients whit acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med 1998; 26: 15-23.
28. Cioffi, WG, Orgura H. Inhaled nitric oxide in acute lung disease. New Horiz 1995; 3: 73-85.
29. Bone RG. Let's agree on terminology: definitions of sepsis. Crit Care Med 1991; 19: 973-976.
30. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. ACCP/SCCM consensus conference. Chest 1992; 101: 1.644-1.655.
31. Davila F. A comparison of clinical and research oxygen-related physiological equations. Intensive Care World 1999; 15: 182-188.
32. Blanch LL, Fernández R, Joseph D, Baigorri F, Valles J, Amas A et al. Inhalación de óxido nítrico en la insuficiencia respiratoria aguda. Efectos gasométricos y hemodinámicos. Medicina Intensiva 1995; 19: 339-405.
33. Hobbs JA, Ignarro LJ. The Nitric Oxide-Cyclic GMP signal transduction system. En: Zippol WM, Kenneth DB, editores. Nitric oxide and the lung. Nueva York: Marcel Dekker. 1997; 1-57.
34. Higenbottan T, Pepke-Zaba J, Scott J, Woolman P, Coutts C, Wallwork J. Inhaled endothelium derived relaxing factor in prymary hipertension. Am Rev Resp Dis 1988; 137: 107A.
35. Sitbon, O, Brenof F, Denjean A, Bergeon A, Parent F, Azarian R et al. Inhaled nitric oxide as a screening vasodilatador agent in primary pulmonary hypertension: a dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med 1995; 151: 384-389.
36. Rovira I. Óxido nítrico. Rev Esp Anestesiol Reanim 1995; 42: 15-23.
37. Gallart L, Rouby JJ, Puig MM. Tratamiento farmacológico de la hipoxemia en el síndrome de distrés respiratorio del adulto. Rev Esp Anestesiol Reanim 1997; 44: 273-283.
38. Radomsky MW, Moncada S. Regulación de la homeostasis vascular mediante óxido nítrico. En: José R Berrazueta, editor. Óxido nítrico endógeno y fármacos nitrovasodilatadores. Santander: Editorial Servicio de Publicaciones de la Universidad de Cantabria, 1994; 45-58.
39. Zeple-Zaba J, Higenbottan TW, Dinh-Xuan AT, Stone D, Walwark J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338: 1.173-1.174.
40. Roberst JD, Polaner DM, Lang P, Zapol WD. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 818-819.
41. Gerlach H, Rossaint R, Pappert D, Falke KJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993; 23: 499-502.
42. Puybasset L, Rouby JJ, Mourgeon E, Cluzel P, Law-Koune JD, Stewart TE et al. Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure. Am J Resp Crit Care Med 1995; 152: 318-328.
43. Betsebé AJ, Pérez M, López-Velarde G, Rialp G, Bak E, Mancebo J. Efectos de la PEEP y del óxido nítrico inhalado en pacientes con insuficiencia respiratoria aguda severa. Med Intensiva 1996; 20: 239-245.
44. Gatt noni L, Pelosi P, Crotti S, Valenza F. Effects of positive end-expiratory pressure on regional distribution of tidal volume and recruitment in adult respiratory distress syndrome. Am J Respir Crit Care 1995; 151: 1.807-1.810
45. Manktelow C, Bigatello LM, Hess D, Hurford WE. Physiologic determinants of the response to inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 1997; 87: 297-307.
46. Stephen RJ, Freeman G, Evans MJ. Early response of lungs to low levels of nitrogen d'oxide. Arch Enviro Health 1972; 24: 160-179.
47. Palmer RMJ. The discovery of nitric oxide in the vessel wall. Arch Surg 1993; 128: 396-401.
48. Crow JP, Beckman JS. The role of peroxynitrito in nitric oxide mediated toxicity. Curr Top Microbiol Immunol 1995; 196: 57-73.
49. Tannenbaum RS. Safety evaluation of inhaled nitric oxide. En: Zappol WM, Kenneth DB. editores. Nitric oxide and the lung. Nueva York: Marcel Dekker, 1997; 247-250.
50. Krafft P, Fridrich P, Pernwerstorfer T, Fitzgerald RD, Koc D, Schneider B et al. The acute respiratory distress syndrome: definitions, severily and clinical outcome. An analysis of 101 clinical investigations. Intensive Care Med 1996; 22: 519-529.
51. Bone RC. The herculean task of treating acute respiratory distress syndrome. Crit Care Med 1996; 24: 3.
52. Vasilyev S, Schaap RN, Mortensen JD. Hospital survival rates of patients with acute respiratory failure in modern respiratory intensive care units: an international multicenter propective survey. Chest 1995; 107: 1.083-1.088.
53. 2 removal in severe acute respiratory failure. JAMA 1986; 256: 881-886.